These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14872465)

  • 41. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.
    Farahani P; Levine M; Gaebel K; Thabane L
    Can J Clin Pharmacol; 2005; 12(3):e254-63. PubMed ID: 16278497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sample-size calculations for studies with correlated ordinal outcomes.
    Kim HY; Williamson JM; Lyles CM
    Stat Med; 2005 Oct; 24(19):2977-87. PubMed ID: 16149125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What we can learn from open-label extensions of randomized clinical trials.
    Cummings JL
    Arch Neurol; 2006 Jan; 63(1):18-9. PubMed ID: 16401732
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of the results of a randomized controlled trial: how to define changes between baseline and follow-up.
    Twisk J; Proper K
    J Clin Epidemiol; 2004 Mar; 57(3):223-8. PubMed ID: 15066681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 46. Design paper: the DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of aerobic versus non-aerobic versus relaxation training for patients with light to moderate depression.
    Krogh J; Petersen L; Timmermann M; Saltin B; Nordentoft M
    Contemp Clin Trials; 2007 Jan; 28(1):79-89. PubMed ID: 16935032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monitoring clinical trials. Several points are contentious.
    Parry D
    BMJ; 2001 Dec; 323(7326):1425. PubMed ID: 11778590
    [No Abstract]   [Full Text] [Related]  

  • 48. Sequential designs for clinical trials in amyotrophic lateral sclerosis.
    Groeneveld GJ; van der Tweel I; Wokke JH; van den Berg LH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):202-7. PubMed ID: 15799547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of statistical analysis in open extension studies.
    Yazici Y; Yazici H
    J Rheumatol; 2006 Feb; 33(2):437; author reply 437-8. PubMed ID: 16465682
    [No Abstract]   [Full Text] [Related]  

  • 50. Organising clinical research: 3. Trial design.
    Mapleson WW
    Br J Clin Pract; 1989 Mar; 43(3):89-93. PubMed ID: 2692689
    [No Abstract]   [Full Text] [Related]  

  • 51. [Support system for medical examination and treatment and for clinical research in rheumatic diseases].
    Matsui T; Tohma S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():699-705. PubMed ID: 15799445
    [No Abstract]   [Full Text] [Related]  

  • 52. The importance of design and analysis in clinical trials.
    Antczak-Bouckoms A; Chalmers TC
    J Oral Implantol; 1988; 14(1):36-42. PubMed ID: 3268694
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of the stepped wedge design cannot be recommended: a critical appraisal and comparison with the classic cluster randomized controlled trial design.
    Kotz D; Spigt M; Arts IC; Crutzen R; Viechtbauer W
    J Clin Epidemiol; 2012 Dec; 65(12):1249-52. PubMed ID: 22964070
    [No Abstract]   [Full Text] [Related]  

  • 54. Evidence for the benefit of aerobic and strengthening exercise in rheumatoid arthritis.
    Stenström CH; Minor MA
    Arthritis Rheum; 2003 Jun; 49(3):428-34. PubMed ID: 12794800
    [No Abstract]   [Full Text] [Related]  

  • 55. On the usefulness of outcome-adaptive randomization.
    Yuan Y; Yin G
    J Clin Oncol; 2011 May; 29(13):e390-2; author reply e393. PubMed ID: 21422433
    [No Abstract]   [Full Text] [Related]  

  • 56. Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
    Strand V; Lassere M; van der Heijde D; Johnson K; Boers M
    J Rheumatol; 2001 Apr; 28(4):887-9. PubMed ID: 11327271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Why and how randomise a clinical trial?].
    Chevret S
    Rev Mal Respir; 2003 Nov; 20(5 Pt 1):753-6. PubMed ID: 14631255
    [No Abstract]   [Full Text] [Related]  

  • 58. Characteristics of cluster randomized trials: are they living up to the randomized trial?
    Selvaraj S; Prasad V
    JAMA Intern Med; 2013 Feb; 173(4):313-5. PubMed ID: 23337957
    [No Abstract]   [Full Text] [Related]  

  • 59. Joint lavage.
    Ayral X; Dougados M
    Rev Rhum Engl Ed; 1995 Apr; 62(4):281-7. PubMed ID: 7606424
    [No Abstract]   [Full Text] [Related]  

  • 60. From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials?
    Baldini C; Delle Sedie A; Bombardieri S
    Clin Exp Rheumatol; 2005; 23(6):893-904. PubMed ID: 16396713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.